导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.89% | 1105/2284 |
| 近一周 | -3.45% | 1972/2316 |
| 近一月 | -5.38% | 1604/2309 |
| 近一季 | -10.32% | 1530/2294 |
| 近半年 | -7.52% | 1604/2292 |
| 近一年 | 8.15% | 835/2266 |
| 近两年 | 44.27% | 1065/2175 |
| 近三年 | 10.53% | 1429/2103 |
| 成立以来 | 63.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.99% 305/2333 |
6.35% 1241/2331 |
- - |
- - |
| 2025 | 21.94% 1147/2338 |
-0.08% 1582/2326 |
3.21% 701/2347 |
15.38% 1292/2344 |
2.49% 589/2338 |
| 2024 | -5.44% 1873/2331 |
-7.46% 1876/2322 |
-4.62% 1695/2326 |
8.01% 1166/2317 |
-0.82% 1200/2331 |
| 2023 | -14.54% 1525/2323 |
3.98% 753/2290 |
-1.60% 1027/2303 |
-12.72% 1867/2318 |
-4.31% 1364/2330 |
| 2022 | -29.06% 1883/2294 |
-22.23% 1977/2227 |
8.36% 625/2269 |
-7.10% 952/2294 |
-9.39% 2136/2300 |
| 2021 | 19.54% 383/2202 |
-15.37% 1950/2009 |
27.21% 107/2060 |
3.19% 423/2103 |
7.60% 291/2208 |
| 2020 | 71.43% 294/2082 |
-3.38% 1391/1861 |
32.87% 126/1950 |
5.11% 1415/2010 |
27.04% 69/2031 |
| 2019 | 49.71% 335/1973 |
26.30% 792/3053 |
-5.03% 2563/3201 |
9.16% 329/1861 |
14.35% 134/1886 |
| 2018 | -29.10% 1506/1913 |
- - |
-7.87% 2204/2983 |
-11.55% 2711/2970 |
-9.66% 1882/2975 |
| 2017 | 13.23% 388/1885 |
- - |
- - |
- - |
- - |
| 2016 | -13.45% 639/1510 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 前海开源医疗健康A | 1.3221 | 43.69% |
| 前海开源医疗健康C | 1.3108 | 43.67% |
| 中信建投医改混合A | 1.9439 | 35.61% |
| 中信建投医改混合C | 1.5821 | 35.48% |
| 国投瑞银医疗保健混合C | 1.1874 | 26.59% |
| 易方达供给改革混合 | 8.1305 | 24.38% |
| 国投瑞银医疗保健混合A | 1.2015 | 24.11% |
| 浦银安盛医疗健康混合A | 1.3373 | 24.10% |
| 先锋聚优A | 1.3980 | 23.90% |
| 先锋聚优C | 1.4204 | 23.84% |
| 华夏国企改革混合 VS. 德邦优化A(770001) |